Therapy Monitoring of Magnetic Resonance–Guided Radiofrequency Ablation Using T1- and T2-Weighted Sequences at 1.5 T
Authors:
- Hansjörg RemppHRHansjörg Rempp
- Johannes UnterbergJUJohannes Unterberg
- Rüdiger HoffmannRHRüdiger Hoffmann
- Philippe L. PereiraPPPhilippe L. Pereira
- Fritz SchickFSFritz Schick
- Claus D. ClaussenCCClaus D. Claussen
- Stephan ClasenSCStephan Clasen
- 1 June 2013
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 48 (6) , 429-436
Abstract
The aim of this study was to compare the size and shape of the indicated ablation zone using magnetic resonance (MR) imaging with different contrast weightings after MR-guided radiofrequency ablation (RFA) at 1.5 T. Magnetic resonance images of 50 patients treated for hepatic malignancies using MR-guided RFA were retrospectively evaluated. Areas indicating ablation zones in contrast-enhanced images were compared with nonenhanced T1- and T2-weighted images acquired after the intervention and 1 and 7 months after therapy. Corresponding slices were selected and registered to each other. Regions indicating ablation zones were segmented and compared. Areas in cm, positive predictive value, and sensitivity of native T1- and T2-weighted images were calculated with regard to their accordance with the contrast-enhanced images. Directly after the intervention, the ratios between the areas of the ablation zone in the contrast-enhanced and the tested sequences were 1.02 ± 0.12 in the T1-weighted images and 2.03 ± 0.78 in the T2-weighted images. Sensitivity (portion of the coagulation zone that was correctly detected based on the tested sequences) was 0.88 ± 0.08 using the T1-weighted and 0.54 ± 0.20 using the T2-weighted images. The positive predictive values were 0.89 ± 0.06 (T1 weighted) and 0.93 ± 0.06 (T2 weighted). One month after therapy, the ratios between the areas in the contrast-enhanced and the tested sequences were 1.02 ± 0.12 in the T1-weighted images and 1.04 ± 0.25 in the T2-weighted images. Seven months after therapy, the ratios were 1.04 ± 0.16 in the T1-weighted and 1.18 ± 0.22 in the T2-weighted images. In examinations performed directly after the intervention, the T2-weighted images tend to underestimate the ablation zone, whereas T1-weighted images clearly better reflect the ablation zone. T1-weighted images therefore seem more adequate for repetitive monitoring of MR-guided RFA at 1.5 T.Keywords
This publication has 27 references indexed in Scilit:
- Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: Preliminary resultsClinical Hemorheology and Microcirculation, 2011
- Observation and correction of transient cavitation-induced PRFS thermometry artifacts during radiofrequency ablation, using simultaneous Ultrasound/MR imagingMedical Physics, 2010
- Real-time monitoring of radiofrequency ablation of liver tumors using thermal-dose calculation by MR temperature imaging: initial results in nine patients, including follow-upEuropean Radiology, 2009
- Prediction of cell necrosis with sequential temperature mapping after radiofrequency ablationJournal of Magnetic Resonance Imaging, 2009
- Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablationEuropean Radiology, 2009
- Analysis of Recurrence Pattern and Its Influence on Survival Outcome After Radiofrequency Ablation of Hepatocellular CarcinomaJournal of Gastrointestinal Surgery, 2008
- Local Recurrence After Hepatic Radiofrequency CoagulationAnnals of Surgery, 2005
- Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis: Long-term Results of Percutaneous Image-guided Radiofrequency AblationRadiology, 2005
- Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasoundEuropean Journal of Radiology, 2004
- Percutaneous Radio-frequency Ablation of Hepatic Metastases from Colorectal Cancer: Long-term Results in 117 PatientsRadiology, 2001